Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Navigating the Roller Coaster of Recent Penny Stock Surges

penny stocks investing

Regarding small-caps and low-float stocks, the market works in cycles. Traders often experience lull periods of hard-to-come-by movers with impressive volume and range. On the other hand, there are periods in the cycle where traders might think that everything will surge 100 to 500% higher. We’re in the latter right now, it seems.

Last week, a remarkable number of penny stocks experienced a surge in volume and price not seen for several years. Everywhere you looked, it seemed like there was a stock trading at $5 that previously closed at $1. 

If you are a new trader, this action could overwhelm you and significantly increase risk. For example, a trader might see a stock up 300% on no news and think it is short, only to surge another 200% higher. Traders looking to participate in this cycle must prioritize risk management and establish a firm edge and system. 

But are the moves in these penny stocks sustainable, and do these companies present an opportunity on a higher time frame, such as an investment? 

Let’s look at three of the biggest movers from last week to gain a better perspective. 

Secoo (NASDAQ: SECO)

Secoo Holding Limited, based in Beijing, China, operates an online and offline shopping platform in China, Hong Kong, and worldwide. It offers upscale brand products and services, including fashion items and electronics. It also serves as a marketplace for third-party merchants to sell luxury goods.

SECO’s average volume is just 2 million shares. However, last Thursday, the stock traded almost 80 million shares and saw its share price rocket to nearly $3 after closing the previous day near $0.30. 

There was no news or catalyst behind the stock’s surge, and as a result, it was unsurprisingly short-lived. After topping out in the high $2’s on Thursday, SECO faded back to close the day out near $1 and the following day near $0.60.

Tempest Therapeutics (NASDAQ: TPST)

Tempest Therapeutics, Inc. is a clinical-stage oncology company based in Brisbane, California. They focus on developing small molecule therapeutics that utilize both tumor-targeted and immune-mediated approaches to treat a variety of tumors. 

Last Wednesday, Tempest Therapeutics saw a remarkable 4,000% increase in its stock after releasing positive Phase 1/2 data for TPST-1120 in treating liver cancer. However, two days after the higher surge, the stock crashed by almost 70% before bouncing back on Monday. Year-to-date, the stock is up nearly 500%, and over the last month, almost 1,300%. 

Judging by the daily 30 - 50% moves in either direction, the market is yet to price the stock fairly, and a battle between shorts and longs is yet to have a clear winner.

OpGen (NASDAQ: OPGN)

OpGen, Inc., based in Rockville, Maryland, is a precision medicine company that develops and sells molecular microbiology solutions worldwide. Their product portfolio includes in vitro diagnostic tests for bacterial nucleic acids and antimicrobial resistance, SARS-CoV-2 test kits, and technology platforms. They collaborate with healthcare institutions to combat infectious diseases and multidrug-resistant infections.

Last Thursday, shares of OPGN surged almost 1000% higher after announcing news and a company update, although not fundamentally changing. After trading to nearly $4 in the morning, having previously closed near $0.30, the stock topped out and gave back the lion's share of its gains, closing the day near $0.90.

Should You Invest in the Penny Stock Mania?

One-word answer: no. As you know, penny stocks and small-cap stocks are inherently riskier than established blue-chip stocks and dividend aristocrats due to their smaller market capitalization, limited resources, and higher volatility. 

Yes, they offer the potential for substantial gains but have a greater risk of losses, making them better suited for speculative investors comfortable with uncertainty and market fluctuations.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.